Research Article

Linc01116沉默通过调节Mir-9-5p/PKG1的表达抑制脊索瘤细胞的增殖和侵袭,促进脊索瘤细胞凋亡

卷 24, 期 8, 2024

发表于: 12 September, 2023

页: [1056 - 1071] 页: 16

弟呕挨: 10.2174/1566524023666230719121758

价格: $65

conference banner
摘要

背景:长基因间非蛋白编码RNA 1116 (LINC01116)在多种癌症中发挥致癌作用。本研究旨在探讨LINC01116和hsa-miR-9-5p (miR-9-5p)的作用,并了解它们在脊索瘤中的相互作用。 方法:通过双荧光素酶报告基因实验证实了starBase预测的miR-9-5p与LINC01116和磷酸甘油酸激酶1 (PGK1)的结合位点。通过细胞计数试剂盒-8 (CCK-8)、集落形成、Transwell和流式细胞术检测转染siLINC01116或miR-9-5p抑制剂的脊索瘤细胞的行为。用特异性试剂盒检测脊索瘤细胞的葡萄糖消耗、乳酸生成和三磷酸腺苷(ATP)生成。采用实时定量聚合酶链反应(qRT-PCR)和Western blot检测相关基因在脊索瘤细胞中的表达。 结果:沉默LINC01116促进了凋亡和Bcl-2-相关X (Bax)、裂解caspase-3 (C caspase-3)和miR-9-5p的表达,同时抑制了细胞周期、活力、增殖、侵袭、葡萄糖消耗、乳酸生成、ATP生成以及PGK1和Bcl-2的表达。同时,LINC01116海绵化miR-9-5p,可靶向PGK1。此外,miR-9-5p抑制剂的作用与之相反,逆转了siLINC01116在脊索瘤细胞中的作用。此外,LINC01116下调可通过上调miR-9-5p的表达,促进脊索瘤细胞凋亡,减弱脊索瘤细胞的增殖和侵袭,降低PGK1的表达。 结论:LINC01116/miR-9-5p在脊索瘤细胞的进展中发挥调节作用,是脊索瘤的潜在生物标志物。

关键词: LINC01116, miR-9-5p,脊索瘤,PGK1,糖酵解,CCK-8。

[1]
Harsh GR IV, Vaz-Guimaraes F. Chordomas and chondrosarcomas of the skull base and spine. Massachusetts: Academic Press 2017.
[2]
Youssef C, Aoun SG, Moreno JR, Bagley CA. Recent advances in understanding and managing chordomas. F1000 Res 2016; 5: 2902.
[http://dx.doi.org/10.12688/f1000research.9499.1] [PMID: 28105324]
[3]
Pillai S, Govender S. Sacral chordoma: A review of literature. J Orthop 2018; 15(2): 679-84.
[http://dx.doi.org/10.1016/j.jor.2018.04.001] [PMID: 29881220]
[4]
Whelan JS, Davis LE. Osteosarcoma, Chondrosarcoma, and Chordoma. J Clin Oncol 2018; 36(2): 188-93.
[http://dx.doi.org/10.1200/JCO.2017.75.1743] [PMID: 29220289]
[5]
Schwab JH, Healey JH, Rose P, Casas-Ganem J, Boland PJ. The surgical management of sacral chordomas. Spine 2009; 34(24): 2700-4.
[http://dx.doi.org/10.1097/BRS.0b013e3181bad11d] [PMID: 19910774]
[6]
Meng T, Jin J, Jiang C, et al. Molecular targeted therapy in the treatment of chordoma: A systematic review. Front Oncol 2019; 9(30): 30.
[http://dx.doi.org/10.3389/fonc.2019.00030] [PMID: 30775316]
[7]
Casali PG, Messina A, Stacchiotti S, Tamborini E, Crippa F, Gronchi A. Imatinib mesylate in chordoma. Cancer 2004; 101(9): 2086-97.
[http://dx.doi.org/10.1002/cncr.20618]
[8]
Zhang R, Xia LQ, Lu WW, Zhang J, Zhu JS. LncRNAs and cancer. Oncol Lett 2016; 12(2): 1233-9.
[http://dx.doi.org/10.3892/ol.2016.4770] [PMID: 27446422]
[9]
Reddy KB. MicroRNA (miRNA) in cancer. Cancer Cell Int 2015; 15(1): 38.
[http://dx.doi.org/10.1186/s12935-015-0185-1] [PMID: 25960691]
[10]
Xue M, Zhuo Y, Shan B. MicroRNAs, long noncoding RNAs, and their functions in human disease. Methods Mol Biol 2017; 1617: 1-25.
[http://dx.doi.org/10.1007/978-1-4939-7046-9_1] [PMID: 28540673]
[11]
Peng W-X, Koirala P, Mo Y-Y. LncRNA-mediated regulation of cell signaling in cancer. Oncogene 2017; 36(41): 5661-7.
[http://dx.doi.org/10.1038/onc.2017.184] [PMID: 28604750]
[12]
Hai B, Pan X, Du C, et al. LncRNA XIST promotes growth of human chordoma cells by regulating miR-124-3p/iASPP pathway. OncoTargets Ther 2020; 13: 4755-65.
[http://dx.doi.org/10.2147/OTT.S252195] [PMID: 32547104]
[13]
Bell D, Raza SM, Bell AH, Fuller GN, DeMonte F. Whole-transcriptome analysis of chordoma of the skull base. Virchows Arch 2016; 469(4): 439-49.
[http://dx.doi.org/10.1007/s00428-016-1985-y] [PMID: 27401718]
[14]
Xu Y, Yu X, Zhang M, et al. Promising advances in LINC01116 related to cancer. Front Cell Dev Biol 2021; 9: 736927.
[http://dx.doi.org/10.3389/fcell.2021.736927] [PMID: 34722518]
[15]
Hu H, Chen Q, Ding SJERMPS. LncRNA LINC01116 competes with miR-145 for the regulation of ESR1 expression in breast cancer. Eur Rev Med Pharmacol Sci 2018; 22(7): 1987-93.
[16]
Su X, Zhang J, Luo X, Yang W, Liu Y, Liu Y, et al. LncRNA LINC01116 promotes cancer cell proliferation, migration and invasion in gastric cancer by positively interacting with lncRNA CASC11. OncoTargets Ther 2019; 12(7): 8117-23.
[17]
Fang Y, Huang Z, Li H, Tan W, Zhang Q, Wang L, et al. LINC01116 promotes the progression of epithelial ovarian cancer via regulating cell apoptosis. Eur Rev Med Pharmacol Sci 2018; 22(16): 5127-33.
[18]
Liu W, Liang F, Yang G, Xian L. LncRNA LINC01116 sponges miR-93-5p to promote cell invasion and migration in small cell lung cancer. BMC Pulm Med 2021; 21(1): 50.
[http://dx.doi.org/10.1186/s12890-020-01369-3] [PMID: 33535997]
[19]
Wu J, Chen Z, Zhang L, Cao J, Li X, Gong Z. Knockdown of LINC01116 inhibits cell migration and invasion in head and neck squamous cell carcinoma through epithelial‐mesenchymal transition pathway. J Cell Biochem 2020; 121(1): 867-75.
[http://dx.doi.org/10.1002/jcb.29331]
[20]
Duan Z, Choy E, Nielsen GP, et al. Differential expression of microRNA (miRNA) in chordoma reveals a role for miRNA-1 in Met expression. J Orthop Res 2010; 28(6): 746-52.
[http://dx.doi.org/10.1002/jor.21055] [PMID: 20041488]
[21]
Huang W, Yan YG, Wang WJ, et al. Development and validation of a 6-miRNA prognostic signature in spinal chordoma. Front Oncol 2020; 10: 556902.
[http://dx.doi.org/10.3389/fonc.2020.556902] [PMID: 33194623]
[22]
Bayrak OF, Gulluoglu S, Aydemir E, et al. MicroRNA expression profiling reveals the potential function of microRNA-31 in chordomas. J Neurooncol 2013; 115(2): 143-51.
[http://dx.doi.org/10.1007/s11060-013-1211-6] [PMID: 23912551]
[23]
Gulluoglu S, Tuysuz EC, Kuskucu A, et al. The potential function of microRNA in chordomas. Gene 2016; 585(1): 76-83.
[http://dx.doi.org/10.1016/j.gene.2016.03.032] [PMID: 27016303]
[24]
Zhang H, Yang K, Ren T, Huang Y, Tang X, Guo W. miR-16-5p inhibits chordoma cell proliferation, invasion and metastasis by targeting Smad3. Cell Death Dis 2018; 9(6): 680.
[http://dx.doi.org/10.1038/s41419-018-0738-z] [PMID: 29880900]
[25]
Zhang K, Liu Z, Wang Z, et al. Long Non-Coding RNA MDFIC-7 promotes chordoma progression through modulating the miR-525-5p/ARF6 axis. Front Oncol 2021; 11: 743718.
[http://dx.doi.org/10.3389/fonc.2021.743718] [PMID: 34621682]
[26]
López-Urrutia E, Bustamante Montes LP, Ladrón de Guevara Cervantes D, Pérez-Plasencia C, Campos-Parra AD. Crosstalk between long non-coding RNAs, Micro-RNAs and mRNAs: Deciphering molecular mechanisms of master regulators in cancer. Front Oncol 2019; 9: 669.
[http://dx.doi.org/10.3389/fonc.2019.00669] [PMID: 31404273]
[27]
Qi X, Zhang DH, Wu N, Xiao JH, Wang X, Ma W. ceRNA in cancer: Possible functions and clinical implications. J Med Genet 2015; 52(10): 710-8.
[http://dx.doi.org/10.1136/jmedgenet-2015-103334] [PMID: 26358722]
[28]
Jiang L, Cheng C, Ji W, et al. LINC01116 promotes the proliferation and invasion of glioma by regulating the microRNA 744 5p MDM2 p53 axis. Mol Med Rep 2021; 23(5): 366.
[http://dx.doi.org/10.3892/mmr.2021.12005] [PMID: 33760190]
[29]
Huang T, Cai M, Chen C, et al. LINC01116 boosts the progression of pituitary adenoma via regulating miR-744–5p/HOXB8 pathway. Mol Cell Endocrinol 2021; 536: 111350.
[http://dx.doi.org/10.1016/j.mce.2021.111350] [PMID: 34098015]
[30]
Cui L, Chen S, Wang D, Yang Q. LINC01116 promotes proliferation and migration of endometrial stromal cells by targeting FOXP1 via sponging miR-9-5p in endometriosis. J Cell Mol Med 2021; 25(4): 2000-12.
[http://dx.doi.org/10.1111/jcmm.16039] [PMID: 33372387]
[31]
Bi C, Cui H, Fan H, Li L. LncRNA LINC01116 promotes the development of colorectal cancer by targeting miR-9-5p/STMN1. OncoTargets Ther 2020; 13: 10547-58.
[http://dx.doi.org/10.2147/OTT.S253532] [PMID: 33116633]
[32]
Chen H, Zhang K, Lu J, Wu G, Yang H, Chen KJO. Comprehensive analysis of mRNA-lncRNA co-expression profile revealing crucial role of imprinted gene cluster DLK1-MEG3 in chordoma. Oncotarget 2017; 8(68): 112623-35.
[http://dx.doi.org/10.18632/oncotarget.22616]
[33]
Bai J, Zhai Y, Wang S, Li M, Zhang S, Li C, et al. LncRNA and mRNA expression profiles reveal the potential roles of lncRNA contributing to regulating dural penetration in clival chordoma. Aging 2020; 12(11): 10809-26.
[http://dx.doi.org/10.18632/aging.103294]
[34]
O’Brien J, Hayder H, Zayed Y, Peng C. Overview of MicroRNA biogenesis, mechanisms of actions, and circulation. Front Endocrinol 2018; 9: 409.
[35]
Temel Y, Santegoeds RGC, Yakkioui Y, Jahanshahi A, Hoogland G, van Overbeeke JJ. Validation of reference genes in human chordoma. Surg Neurol Int 2017; 8(1): 100.
[http://dx.doi.org/10.4103/sni.sni_399_16] [PMID: 28695047]
[36]
Ganapathy-Kanniappan S, Geschwind JFH. Tumor glycolysis as a target for cancer therapy: Progress and prospects. Mol Cancer 2013; 12(1): 152.
[http://dx.doi.org/10.1186/1476-4598-12-152] [PMID: 24298908]
[37]
Chen JY, Xu LF, Hu HL, Wen YQ, Chen D, Liu WH. MiRNA-215-5p alleviates the metastasis of prostate cancer by targeting PGK1. Eur Rev Med Pharmacol Sci 2020; 24(2): 639-46.
[PMID: 32017004]
[38]
Beaver LM, Kuintzle R, Buchanan A, et al. Long noncoding RNAs and sulforaphane: A target for chemoprevention and suppression of prostate cancer. J Nutr Biochem 2017; 42: 72-83.
[http://dx.doi.org/10.1016/j.jnutbio.2017.01.001] [PMID: 28131897]
[39]
Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)). Method Methods 2001; 25(4): 402-8.
[http://dx.doi.org/10.1006/meth.2001.1262] [PMID: 11846609]
[40]
Wang CB, Wang Y, Wang JJ, Guo XL. LINC00662 triggers malignant progression of chordoma by the activation of RNF144B via targeting miR-16-5p. Eur Rev Med Pharmacol Sci 2020; 24(3): 1007-22.
[PMID: 32096180]
[41]
Meng L, Xing Z, Guo Z, Liu ZJCD. LINC01106 post-transcriptionally regulates ELK3 and HOXD8 to promote bladder cancer progression. Cell Death & Dis 2020; 11(12): 1-15.
[42]
Zeng L, Lyu X, Yuan J, Wang W, Zhao N, Liu B, et al. Long non-coding RNA LINC01116 is overexpressed in lung adenocarcinoma and promotes tumor proliferation and metastasis. Am J Transl Res 2020; 12(8): 4302-13.
[43]
Zhang Z, Xu H, Hu W, Hu T, Wang XJERMPS. LINC01116 promotes proliferation, invasion and migration of osteosarcoma cells by silencing p53 and EZH2. Eur Rev Med Pharmacol Sci 2019; 23(16): 6813-23.
[44]
Wong RSY. Apoptosis in cancer: From pathogenesis to treatment. J Exp Clin Cancer Res 2011; 30(1): 87.
[http://dx.doi.org/10.1186/1756-9966-30-87] [PMID: 21943236]
[45]
Chen J, Yuan ZH, Hou XH, Shi MH, Jiang R. LINC01116 promotes the proliferation and inhibits the apoptosis of gastric cancer cells. Eur Rev Med Pharmacol Sci 2020; 24(4): 1807-14.
[PMID: 32141549]
[46]
Fan X, Sun Y, Guo X, He C, Han B, Sun XJCB. Long non-coding RNA LINC01116 regulated miR-744-5p/SCN1B axis to exacerbate lung squamous cell carcinoma. Cancer Biomark 2020; 28(4): 1-10.
[47]
Wang J, Gao J, Chen Q, et al. LncRNA LINC01116 Contributes to Cisplatin Resistance in Lung Adenocarcinoma. OncoTargets Ther 2020; 13: 9333-47.
[http://dx.doi.org/10.2147/OTT.S244879] [PMID: 33061421]
[48]
Shang B, Li Z, Li M, et al. Silencing LINC01116 suppresses the development of lung adenocarcinoma via the AKT signaling pathway. Thorac Cancer 2021; 12(14): 2093-103.
[http://dx.doi.org/10.1111/1759-7714.14042] [PMID: 34061456]
[49]
Suhaili SH, Karimian H, Stellato M, Lee TH, Aguilar MI. Mitochondrial outer membrane permeabilization: A focus on the role of mitochondrial membrane structural organization. Biophys Rev 2017; 9(4): 443-57.
[http://dx.doi.org/10.1007/s12551-017-0308-0] [PMID: 28823106]
[50]
Shamas-Din A, Kale J, Leber B, Andrews DW. Mechanisms of action of Bcl-2 family proteins. Cold Spring Harb Perspect Biol 2013; 5(4): a008714.
[http://dx.doi.org/10.1101/cshperspect.a008714] [PMID: 23545417]
[51]
Williams GH, Stoeber K. The cell cycle and cancer. J Pathol 2012; 226(2): 352-64.
[http://dx.doi.org/10.1002/path.3022]
[52]
Matthews HK, Bertoli C, de Bruin RAM. Cell cycle control in cancer. Nat Rev Mol Cell Biol 2022; 23(1): 74-88.
[http://dx.doi.org/10.1038/s41580-021-00404-3] [PMID: 34508254]
[53]
Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nature 2001; 411(6835): 342-8.
[http://dx.doi.org/10.1038/35077213] [PMID: 11357141]
[54]
Yang J, Ren B, Yang G, et al. The enhancement of glycolysis regulates pancreatic cancer metastasis. Cell Mol Life Sci 2020; 77(2): 305-21.
[http://dx.doi.org/10.1007/s00018-019-03278-z] [PMID: 31432232]
[55]
Akram M. Mini-review on glycolysis and cancer. J Cancer Educ 2013; 28(3): 454-7.
[http://dx.doi.org/10.1007/s13187-013-0486-9] [PMID: 23728993]
[56]
Bowler MW. Conformational dynamics in phosphoglycerate kinase, an open and shut case? FEBS Lett 2013; 587(13): 1878-83.
[http://dx.doi.org/10.1016/j.febslet.2013.05.012] [PMID: 23684636]
[57]
Chen Z, Tao Q, Qiao B. Silencing of LINC01116 suppresses the development of oral squamous cell carcinoma by up-regulating microRNA-136 to inhibit FN1. Cancer Manag Res 2019; 11: 6043-59.
[58]
Yuan W, Sun H, Yu LJB. Long non-coding RNA LINC01116 accelerates the progression of keloid formation by regulating miR-203/SMAD5 axis. Burns 2021; 47(3): 665-1675.
[59]
Wang L, Cui M, Cheng D, et al. miR-9-5p facilitates hepatocellular carcinoma cell proliferation, migration and invasion by targeting ESR1. Mol Cell Biochem 2021; 476(2): 575-83.
[http://dx.doi.org/10.1007/s11010-020-03927-z] [PMID: 33106914]
[60]
Zhu K, Lin J, Chen S, Xu Q. miR-9-5p promotes lung adenocarcinoma cell proliferation, migration and invasion by targeting ID4. Technol Cancer Res Treat 2021; 20.
[http://dx.doi.org/10.1177/15330338211048592] [PMID: 34723712]
[61]
Chen L, Hu W, Li G, Guo Y, Wan Z, Yu J. Inhibition of miR-9-5p suppresses prostate cancer progress by targeting StarD13. Cell Mol Biol Lett 2019; 24(1): 20.
[http://dx.doi.org/10.1186/s11658-019-0145-1] [PMID: 30899277]
[62]
Ying M, Feng H, Zhang X, Liu R, Ning H. MiR-9-5p inhibits the proliferation, migration and invasion of choroidal melanoma by targeting BRAF. Technol Cancer Res Treat 2020; 19.
[http://dx.doi.org/10.1177/1533033820956987] [PMID: 33138697]
[63]
Wang J, Wang B, Ren H, Chen W. miR-9-5p inhibits pancreatic cancer cell proliferation, invasion and glutamine metabolism by targeting GOT1. Biochem Biophys Res Commun 2019; 509(1): 241-8.
[http://dx.doi.org/10.1016/j.bbrc.2018.12.114] [PMID: 30591220]
[64]
Babion I, Jaspers A, van Splunter AP, van der Hoorn IAE, Wilting SM, Steenbergen RDM. miR-9-5p exerts a dual role in cervical cancer and targets transcription factor TWIST1. Cells 2019; 9(1): 65.
[http://dx.doi.org/10.3390/cells9010065] [PMID: 31888045]
[65]
Yoon JH, Abdelmohsen K, Gorospe M. Functional interactions among microRNAs and long noncoding RNAs. Semin Cell Dev Biol 2014; 34: 9-14.
[http://dx.doi.org/10.1016/j.semcdb.2014.05.015] [PMID: 24965208]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy